Arsène Zongo

546 total citations
37 papers, 293 citations indexed

About

Arsène Zongo is a scholar working on Pharmacology, Geriatrics and Gerontology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Arsène Zongo has authored 37 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Geriatrics and Gerontology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Arsène Zongo's work include Cannabis and Cannabinoid Research (10 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Medication Adherence and Compliance (9 papers). Arsène Zongo is often cited by papers focused on Cannabis and Cannabinoid Research (10 papers), Pharmaceutical Practices and Patient Outcomes (10 papers) and Medication Adherence and Compliance (9 papers). Arsène Zongo collaborates with scholars based in Canada, Burkina Faso and France. Arsène Zongo's co-authors include Line Guénette, Carlotta Lunghi, Dean T. Eurich, Jocelyne Moisan, Jean‐Pierre Grégoire, Baiju R. Shah, Mhd Wasem Alsabbagh, Wajd Alkabbani, Marie‐Laure Laroche and John‐Michael Gamble and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biological Conservation.

In The Last Decade

Arsène Zongo

34 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arsène Zongo Canada 10 95 69 64 59 56 37 293
Joli D. Fermo United States 9 100 1.1× 34 0.5× 79 1.2× 40 0.7× 44 0.8× 17 321
Feng-Hwa Lu Taiwan 10 61 0.6× 35 0.5× 99 1.5× 30 0.5× 84 1.5× 30 509
Reidun Lisbet Skeide Kjome Norway 11 81 0.9× 40 0.6× 153 2.4× 16 0.3× 41 0.7× 31 327
Todd R. Marcy United States 10 64 0.7× 43 0.6× 64 1.0× 26 0.4× 41 0.7× 16 306
Joseph Couto United States 8 62 0.7× 47 0.7× 47 0.7× 48 0.8× 46 0.8× 15 462
E. Paul Larrat United States 11 28 0.3× 72 1.0× 132 2.1× 42 0.7× 51 0.9× 19 360
Helen Berlie United States 11 220 2.3× 23 0.3× 63 1.0× 53 0.9× 48 0.9× 25 551
Varsha Patel India 11 52 0.5× 12 0.2× 90 1.4× 35 0.6× 49 0.9× 37 335
Heather Falvey United States 10 150 1.6× 121 1.8× 53 0.8× 26 0.4× 28 0.5× 32 576
Adeladlew Kassie Netere Ethiopia 9 123 1.3× 46 0.7× 43 0.7× 10 0.2× 83 1.5× 25 306

Countries citing papers authored by Arsène Zongo

Since Specialization
Citations

This map shows the geographic impact of Arsène Zongo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arsène Zongo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arsène Zongo more than expected).

Fields of papers citing papers by Arsène Zongo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arsène Zongo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arsène Zongo. The network helps show where Arsène Zongo may publish in the future.

Co-authorship network of co-authors of Arsène Zongo

This figure shows the co-authorship network connecting the top 25 collaborators of Arsène Zongo. A scholar is included among the top collaborators of Arsène Zongo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arsène Zongo. Arsène Zongo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laroche, Marie‐Laure, Marc Labétoulle, Émilie Jouanjus, Edeltraut Kröger, & Arsène Zongo. (2025). Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France. Fundamental and Clinical Pharmacology. 39(4). e70028–e70028. 2 indexed citations
2.
3.
Zongo, Arsène, et al.. (2025). Seasonal effects of farmer‐managed livestock grazing exclusions on bird communities in Burkina Faso. Ecological Applications. 35(8). e70160–e70160.
4.
Zongo, Arsène, et al.. (2024). The potential of farmer-managed small-scale grazing exclusions as an adaptive management to restore degraded lands in arid regions. Biological Conservation. 302. 110949–110949. 1 indexed citations
5.
Lunghi, Carlotta, Dean T. Eurich, Jason R.B. Dyck, et al.. (2024). Medical cannabis authorization and risk of emergency department visits and hospitalization due to psychotic disorders: A propensity score-matched cohort study. Schizophrenia Research. 264. 534–542.
6.
Eurich, Dean T., et al.. (2023). Risk of depressive disorders associated with medical cannabis authorization: A propensity score matched cohort study. Psychiatry Research. 320. 115047–115047. 4 indexed citations
7.
Zongo, Arsène, et al.. (2023). Utilisation des médicaments traditionnels chez les praticiens de la médecine conventionnelle au Burkina Faso. Santé Publique. Vol. 35(1). 75–86. 1 indexed citations
8.
Zongo, Arsène, et al.. (2023). Phytopharmaceutical practices of traditional health practitioners in Burkina Faso: a cross-sectional study. BMC Complementary Medicine and Therapies. 23(1). 215–215. 5 indexed citations
9.
Lunghi, Carlotta, et al.. (2023). Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal Studies. Pain Management Nursing. 25(1). e8–e20. 2 indexed citations
10.
Zongo, Arsène, et al.. (2023). Current Status and Challenges of Pharmacovigilance of Traditional Medicines in French-Speaking West African (UEMOA) Countries. Pharmaceutical Medicine. 37(4). 305–318. 2 indexed citations
11.
Alkabbani, Wajd, Baiju R. Shah, Arsène Zongo, et al.. (2023). Post‐initiation predictors of discontinuation of the sodium‐glucose cotransporter‐2 inhibitors: A comparative cohort study from the United Kingdom. Diabetes Obesity and Metabolism. 25(12). 3490–3500. 5 indexed citations
12.
Barbier, Olivier, Anne Gangloff, Jacinthe Leclerc, et al.. (2023). Relationship Between Diet Quality and Statin Use Among Adults With Metabolic Syndrome From the CARTaGENE Cohort. CJC Open. 6(1). 11–19. 4 indexed citations
13.
Barbier, Olivier, Line Guénette, Jacinthe Leclerc, et al.. (2023). Relationship Between Diet Quality and Glucose-Lowering Medication Intensity Among Adults With Type 2 Diabetes: Results From the CARTaGENE Cohort. CJC Open. 6(1). 20–29. 3 indexed citations
14.
15.
Alkabbani, Wajd, Arsène Zongo, Jasjeet K. Minhas‐Sandhu, et al.. (2021). Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study. Canadian Journal of Diabetes. 46(4). 392–403.e13. 18 indexed citations
16.
Alkabbani, Wajd, John‐Michael Gamble, Dean T. Eurich, et al.. (2021). Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs. Diabetes & Metabolism. 48(2). 101305–101305. 4 indexed citations
17.
Eurich, Dean T., et al.. (2019). Cohort study of medical cannabis authorisation and healthcare utilisation in 2014–2017 in Ontario, Canada. Journal of Epidemiology & Community Health. 74(3). 299–304. 7 indexed citations
18.
Lunghi, Carlotta, Arsène Zongo, Jocelyne Moisan, Jean‐Pierre Grégoire, & Line Guénette. (2017). The impact of incident depression on medication adherence in patients with type 2 diabetes. Diabetes & Metabolism. 43(6). 521–528. 26 indexed citations
19.
Zongo, Arsène, Line Guénette, Jocelyne Moisan, et al.. (2016). Revisiting the internal consistency and factorial validity of the 8-item Morisky Medication Adherence Scale. SAGE Open Medicine. 4. 2103746850–2103746850. 9 indexed citations
20.
Zongo, Arsène, Line Guénette, Jocelyne Moisan, & Jean‐Pierre Grégoire. (2015). Predictive Validity of Self-Reported Measures of Adherence to Noninsulin Antidiabetes Medication against Control of Glycated Hemoglobin Levels. Canadian Journal of Diabetes. 40(1). 58–65. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joli D. Fermo Breakdown of academic impact, for papers by Feng-Hwa Lu Breakdown of academic impact, for papers by Reidun Lisbet Skeide Kjome Breakdown of academic impact, for papers by Todd R. Marcy Breakdown of academic impact, for papers by Joseph Couto Breakdown of academic impact, for papers by E. Paul Larrat Breakdown of academic impact, for papers by Helen Berlie Breakdown of academic impact, for papers by Varsha Patel Breakdown of academic impact, for papers by Heather Falvey Breakdown of academic impact, for papers by Adeladlew Kassie Netere
Rankless by CCL
2026